AG0302-COVID‑19
Vaccine candidate against COVID-19 / From Wikipedia, the free encyclopedia
AG0302-COVID-19 is a COVID-19 vaccine candidate developed by AnGes Inc.[2][3] This candidate followed a previous one called AG0301-COVID-19.[4]
Quick Facts Vaccine description, Target ...
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | DNA |
Clinical data | |
Routes of administration | Intramuscular, Intradermal[1] |
Close